Solange Landreville
Publications récentes
Weidmann C, Berube J, Piquet L, de la Fouchardiere A, Landreville S. Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines. Clin Exp Metastasis, 35 (3), p. 123-134, 2018, ISSN: 0262-0898
Bergeron E, Lihimdi N, Bergeron D, Landreville S. Orbital recurrence of iris melanoma 21 years after enucleation. BMJ Case Rep, 2017 , 2017, ISSN: 1757-790X
Weidmann C, Pomerleau J, Trudel-Vandal L, Landreville S. Differential responses of choroidal melanocytes and uveal melanoma cells to low oxygen conditions. Mol Vis, 23 , p. 103-115, 2017
Mouriaux F, Zaniolo K, Bergeron MA, Weidmann C, De La Fouchardiere A, Fournier F, Droit A, Morcos MW, Landreville S, Guerin SL. Effects of Long-term Serial Passaging on the Characteristics and Properties of Cell Lines Derived From Uveal Melanoma Primary Tumors. Invest Ophthalmol Vis Sci, 57 (13), p. 5288-5301, 2016, ISSN: 0146-0404
Bisson F, Paquet C, Bourget JM, Zaniolo K, Rochette PJ, Landreville S, Damour O, Boudreau F, Auger FA, Guerin SL, Germain L. Contribution of Sp1 to Telomerase Expression and Activity in Skin Keratinocytes Cultured With a Feeder Layer. J Cell Physiol, 230 (2), p. 308-17, 2015, ISSN: 0021-9541
Calipel A, Landreville S, De La Fouchardiere A, Mascarelli F, Rivoire M, Penel N, Mouriaux F. Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma. Clin Exp Metastasis, 31 (5), p. 553-64, 2014, ISSN: 0262-0898
Mouriaux F, Sanschagrin F, Diorio C, Landreville S, Comoz F, Petit E, Bernaudin M, Rousseau AP, Bergeron D, Morcos M. Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma. Invest Ophthalmol Vis Sci, 55 (3), p. 1277-83, 2014, ISSN: 0146-0404
Fu M, Landreville S, Agapova OA, Wiley LA, Shoykhet M, Harbour JW, Heuckeroth RO. Retinoblastoma protein prevents enteric nervous system defects and intestinal pseudo-obstruction. J Clin Invest, 123 (12), p. 5152-64, 2013, ISSN: 0021-9738
Landreville S, Agapova OA, Matatall KA, Kneass ZT, Onken MD, Lee RS, Bowcock AM, Harbour JW. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin Cancer Res, 18 (2), p. 408-16, 2012, ISSN: 1078-0432
Bergeron MA, Champagne S, Gaudreault M, Deschambeault A, Landreville S. Repression of genes involved in melanocyte differentiation in uveal melanoma. Mol Vis, 18 , p. 1813-22, 2012
Landreville S, Vigneault F, Bergeron MA, Leclerc S, Gaudreault M, Morcos M, Mouriaux F, Salesse C, Guerin SL. Suppression of α5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines. Pigment Cell Melanoma Res, 24 (4), p. 643-55, 2011, ISSN: 1755-1471
Landreville S, Agapova OA, Kneass ZT, Salesse C, Harbour JW. ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity.Pigment Cell Melanoma Res, 24 (3), p. 430-7, 2011, ISSN: 1755-1471
Landreville S, Lupien CB, Vigneault F, Gaudreault M, Mathieu M, Rousseau AP, Guerin SL, Salesse C. Identification of differentially expressed genes in uveal melanoma using suppressive subtractive hybridization. Mol Vis, 17 , p. 1324-33, 2011
Landreville S, Ma D, Wu J, Harbour JW. Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.Curr Eye Res, 35 (5), p. 435-9, 2010, ISSN: 0271-3683
Landreville S, Agapova OA, Harbour JW. Emerging insights into the molecular pathogenesis of uveal melanoma.Future Oncol, 4 (5), p. 629-36, 2008, ISSN: 1479-6694